ArticleCureus2024
Venous Sinus Stenting for Idiopathic Intracranial Hypertension: A Report of Two Cases.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Time is vision: a systematic review of urgent venous sinus stenting for fulminant idiopathic intracranial hypertension.Frontiers in neurologyPooled it
- VIVA Stent Preclinical Evaluation in Swine: A Novel Cerebral Venous Stent with a Unique Delivery System.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic intracranial hypertension (IIH) is characterized by an elevated intracranial pressure of unknown cause, which can lead to severe and sometimes irreversible visual impairment. Recently, venous sinus stenting (VSS) has emerged as an alternative treatment option for IIH. Here, we report two patients with IIH who successfully underwent VSS in the transverse sinus and displayed rapid improvement in visual symptoms. Two young women presented with progressive visual symptoms of papilledema. The cerebrospinal fluid (CSF) opening pressures were elevated higher than 40 cmH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.